Prevalence of anti cyclic citrullinated peptide antibodies in Malaysian rheumatoid arthritis patients and its correlation with disease activity

International Journal of Rheumatic Diseases

Volumn 12, Issue 3, 2009, Pages 211-215

  Sockalingam, Sargunan ^a   Khuan, Chow Sook ^b   Sthaneshwar, Pavai ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

Anti cyclic citrullinated peptide antibodies; Clinical aspects; DAS 28; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; RHEUMATOID FACTOR;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE DURATION; DRUG USE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; MALE; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADULT; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALAYSIA; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; SEROEPIDEMIOLOGIC STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 69149097705     PISSN: 17561841     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2009.01412.x     Document Type: Article

References (25)

1. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002) Special Article - Guidelines for the management Rheumatoid Arthritis 2002 Update. Arthritis Rheum 46, 328-346.
2. Shipley M, Black CM, Compston J, O'Gradaigh D (2002) Rheumatology and bone disease. In: Kumar P, Clark M (eds) Clinical Medicine 5th Edn, pp 516. W B Saunders Co., London.
3. Lipsky PE (2001) Rheumatoid arthritis. In: Braunwald E, Fauci AS, Casper DL, Hauser SL, Longo DL, Jameson JL (eds) Harrison's Principles of Internal Medicine, 15th edn., pp 312. McGraw-Hill, New York.
4. Lee DM, Schuur PH (2003) Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 62, 870-874.
5. Saraux A, Berthelot JM, Charles G, et al. (2002) Value of laboratory tests in early prediction of rheumatoid arthritis. Arthritis Rheum 47, 155-165.
6. Bas S, Perneger TV, Seitz M, Tiercy JM, Roux-Lombard P, Guerne PA (2002) Diagnostic tests for Rheumatoid Arthritis: Comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology 41, 809-14.
7. Utz PJ, Genovese MC, Robinson WH (2004) Unlocking the PAD lock on rheumatoid arthritis. Ann Rheum Dis 63, 330-332.
8. Vossenaar ER, Radstake TRD, van der Heijden A, et al. (2004) Expression and activity of citrullinating peptidylarginine deiminase enzymes in monoytes and macrophages. Ann Rheum Dis 63, 373-381.
9. Rantapää-Dahlqvist S, de Jong BAW, Berglin E, et al. (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48, 2741-2749.
10. Dubucquoi S, Solau-Gervais E, Lefranc D, et al. (2004) Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases. Ann Rheum Dis 63, 415-419.
11. Nell VPK, Machold KP, Eberl G, et al. (2003) The diagnostic and prognostic significance of autoantibodies in patients with very early arthritis. Arthritis Rheum 48(Suppl.), 167.
12. Wong AL, Harker JO, Park GS, Paulus HE (2003) Agreement of ACR 20 with patient self reporting disease activity indices in a clinical practice setting. Arthritis Rheum 48(Suppl.), 1148.
13. Prevoo M, van't Hof M, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty eight joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38, 44-48.
14. Bingham SJ, Emery P (1999-2000) Targeting patients with resistant rheumatoid arthritis. In: Emery P (ed) Rheumatology Highlights 1999-2000 p. 30. Health Press Ltd., London.
15. Salvador G, Gomez A, Viñas O, et al. (2003) Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis?. Rheumatology 42, 972-975.
16. Bizzaro N, Mazzanti G, Villalta ETD, Tozzoli R (2001) Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47, 1089-1093.
17. Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL (2004) Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. J Rheumatol 31(9), 1829-1833.
18. Wu CC, Lin KM, Lai HM, et al. (2006) The diagnostic value of anti-CCP and rheumatoid factor for patients with refractory rheumatoid arthritis (RA) and RA in remission. J Rheumatol 20, 25-30.
19. Nishimura K, Sugiyama D, Yogata Y, et al. (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146, 797-808.
20. Kastbom A, Stranberg G, Lindroos A, Skogh T (2004) Anti-CCP antibody tests predicts the disease course during 3 years in early rheumatoid arthritis (The Swedish TIRA project). Ann Rheum Dis 63, 1085-1089.
21. Stolt P, Bengtsson C, Nordmark B, et al. (2003) Quantification of the influence of cigarette smoking on rheumatoid arthritis: Results from a population based case-control study, using incident cases. Ann Rheum Dis 62, 835-841.
22. Silman AJ, Newman J, MacGregor AJ (1996) Cigarette smoking increases the risk of rheumatoid arthritis. Arthritis Rheum 39(5), 732-735.
23. Niewold TB, Harrison MJ, Paget SA (2007) Anti-CCP as a diagnostic and prognostic tool in rheumatoid arthritis. Q J Med 100, 193-201.
24. Klareskog L, Stolt P, Lundberg K, et al. (2006) A new model for an etiology of rheumatoid arthritis. Arthritis Rheum 54(1), 38-46.
25. Irigoyen P, Lee AT, Wener MH, et al. (2005) Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis. Arthritis Rheum 52(12), 3813-3818.